280 related articles for article (PubMed ID: 17192636)
1. Alpha-conotoxin analogs with enhanced affinity for nicotinic receptors and acetylcholine-binding proteins.
Tsetlin VI; Kasheverov IE; Zhmak MN; Utkin YN; Vulfius CA; Smit AB; Bertrand D
J Mol Neurosci; 2006; 30(1-2):77-8. PubMed ID: 17192636
[TBL] [Abstract][Full Text] [Related]
2. Alpha-conotoxin analogs with additional positive charge show increased selectivity towards Torpedo californica and some neuronal subtypes of nicotinic acetylcholine receptors.
Kasheverov IE; Zhmak MN; Vulfius CA; Gorbacheva EV; Mordvintsev DY; Utkin YN; van Elk R; Smit AB; Tsetlin VI
FEBS J; 2006 Oct; 273(19):4470-81. PubMed ID: 16956365
[TBL] [Abstract][Full Text] [Related]
3. Interaction of alpha-conotoxin ImII and its analogs with nicotinic receptors and acetylcholine-binding proteins: additional binding sites on Torpedo receptor.
Kasheverov IE; Zhmak MN; Fish A; Rucktooa P; Khruschov AY; Osipov AV; Ziganshin RH; D'hoedt D; Bertrand D; Sixma TK; Smit AB; Tsetlin VI
J Neurochem; 2009 Nov; 111(4):934-44. PubMed ID: 19712060
[TBL] [Abstract][Full Text] [Related]
4. Determinants involved in the affinity of alpha-conotoxins GI and SI for the muscle subtype of nicotinic acetylcholine receptors.
Groebe DR; Gray WR; Abramson SN
Biochemistry; 1997 May; 36(21):6469-74. PubMed ID: 9174364
[TBL] [Abstract][Full Text] [Related]
5. NMR solution structure of alpha-conotoxin ImI and comparison to other conotoxins specific for neuronal nicotinic acetylcholine receptors.
Rogers JP; Luginbühl P; Shen GS; McCabe RT; Stevens RC; Wemmer DE
Biochemistry; 1999 Mar; 38(13):3874-82. PubMed ID: 10194298
[TBL] [Abstract][Full Text] [Related]
6. Determination of alpha-conotoxin binding modes on neuronal nicotinic acetylcholine receptors.
Dutertre S; Nicke A; Tyndall JD; Lewis RJ
J Mol Recognit; 2004; 17(4):339-47. PubMed ID: 15227641
[TBL] [Abstract][Full Text] [Related]
7. alpha-Conotoxins selectively inhibit one of the two acetylcholine binding sites of nicotinic receptors.
Groebe DR; Dumm JM; Levitan ES; Abramson SN
Mol Pharmacol; 1995 Jul; 48(1):105-11. PubMed ID: 7623764
[TBL] [Abstract][Full Text] [Related]
8. Alpha-conotoxins ImI and ImII target distinct regions of the human alpha7 nicotinic acetylcholine receptor and distinguish human nicotinic receptor subtypes.
Ellison M; Gao F; Wang HL; Sine SM; McIntosh JM; Olivera BM
Biochemistry; 2004 Dec; 43(51):16019-26. PubMed ID: 15609996
[TBL] [Abstract][Full Text] [Related]
9. alpha-Conotoxin ImI exhibits subtype-specific nicotinic acetylcholine receptor blockade: preferential inhibition of homomeric alpha 7 and alpha 9 receptors.
Johnson DS; Martinez J; Elgoyhen AB; Heinemann SF; McIntosh JM
Mol Pharmacol; 1995 Aug; 48(2):194-9. PubMed ID: 7651351
[TBL] [Abstract][Full Text] [Related]
10. Novel alpha-conotoxins from Conus spurius and the alpha-conotoxin EI share high-affinity potentiation and low-affinity inhibition of nicotinic acetylcholine receptors.
López-Vera E; Aguilar MB; Schiavon E; Marinzi C; Ortiz E; Restano Cassulini R; Batista CV; Possani LD; Heimer de la Cotera EP; Peri F; Becerril B; Wanke E
FEBS J; 2007 Aug; 274(15):3972-85. PubMed ID: 17635581
[TBL] [Abstract][Full Text] [Related]
11. Polypeptide and peptide toxins, magnifying lenses for binding sites in nicotinic acetylcholine receptors.
Tsetlin V; Utkin Y; Kasheverov I
Biochem Pharmacol; 2009 Oct; 78(7):720-31. PubMed ID: 19501053
[TBL] [Abstract][Full Text] [Related]
12. Crystal structure at 1.1 A resolution of alpha-conotoxin PnIB: comparison with alpha-conotoxins PnIA and GI.
Hu SH; Gehrmann J; Alewood PF; Craik DJ; Martin JL
Biochemistry; 1997 Sep; 36(38):11323-30. PubMed ID: 9298951
[TBL] [Abstract][Full Text] [Related]
13. Alpha-conotoxin residues that interact at close range with gamma-tyrosine-111 and mutant delta-tyrosine-113 on the Torpedo nicotinic acetylcholine receptor.
Vélez-Carrasco W; Valdés S; Agresar L; Lettich A; Guerra AY; Hann RM
Biochemistry; 2004 Oct; 43(39):12700-8. PubMed ID: 15449960
[TBL] [Abstract][Full Text] [Related]
14. alpha-Conotoxin GI benzoylphenylalanine derivatives. (1)H-NMR structures and photoaffinity labeling of the Torpedo californica nicotinic acetylcholine receptor.
Kasheverov IE; Chiara DC; Zhmak MN; Maslennikov IV; Pashkov VS; Arseniev AS; Utkin YN; Cohen JB; Tsetlin VI
FEBS J; 2006 Apr; 273(7):1373-88. PubMed ID: 16689926
[TBL] [Abstract][Full Text] [Related]
15. Identification of residues that confer alpha-conotoxin-PnIA sensitivity on the alpha 3 subunit of neuronal nicotinic acetylcholine receptors.
Everhart D; Reiller E; Mirzoian A; McIntosh JM; Malhotra A; Luetje CW
J Pharmacol Exp Ther; 2003 Aug; 306(2):664-70. PubMed ID: 12734390
[TBL] [Abstract][Full Text] [Related]
16. RegIIA: an α4/7-conotoxin from the venom of Conus regius that potently blocks α3β4 nAChRs.
Franco A; Kompella SN; Akondi KB; Melaun C; Daly NL; Luetje CW; Alewood PF; Craik DJ; Adams DJ; Marí F
Biochem Pharmacol; 2012 Feb; 83(3):419-26. PubMed ID: 22108175
[TBL] [Abstract][Full Text] [Related]
17. Iodo-alpha-conotoxin MI selectively binds the alpha/delta subunit interface of muscle nicotinic acetylcholine receptors.
Luo S; McIntosh JM
Biochemistry; 2004 Jun; 43(21):6656-62. PubMed ID: 15157099
[TBL] [Abstract][Full Text] [Related]
18. Involvement of alpha6/alpha3 neuronal nicotinic acetylcholine receptors in neuropsychiatric features of Dementia with Lewy bodies: [(125)I]-alpha-conotoxin MII binding in the thalamus and striatum.
Ray M; Bohr I; McIntosh JM; Ballard C; McKeith I; Chalon S; Guilloteau D; Perry R; Perry E; Court JA; Piggott M
Neurosci Lett; 2004 Dec; 372(3):220-5. PubMed ID: 15542244
[TBL] [Abstract][Full Text] [Related]
19. Analogs of alpha-conotoxin MII are selective for alpha6-containing nicotinic acetylcholine receptors.
McIntosh JM; Azam L; Staheli S; Dowell C; Lindstrom JM; Kuryatov A; Garrett JE; Marks MJ; Whiteaker P
Mol Pharmacol; 2004 Apr; 65(4):944-52. PubMed ID: 15044624
[TBL] [Abstract][Full Text] [Related]
20. Efficient binding of 4/7 α-conotoxins to nicotinic α4β2 receptors is prevented by Arg185 and Pro195 in the α4 subunit.
Beissner M; Dutertre S; Schemm R; Danker T; Sporning A; Grubmüller H; Nicke A
Mol Pharmacol; 2012 Oct; 82(4):711-8. PubMed ID: 22802270
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
